True Nature Updates on Retail Strategy, Compounding and Staffing
ATLANTA, GA--(Marketwired - Aug 2, 2017) - True Nature Holding, Inc. (OTCQB: TNTY) (the "Company") today provides an update on its previously announced actions on business development and staffing:
Price Choice Pharmacy Acquisition:
On January 19, 2017 the Company entered into a Letter of Intent ("LOI") to acquire the two (2) retail operations of Price Choice Pharmacy in Miami, Florida. On July 27, 2017, however, the Company was informed by the seller that it received an alternative proposal from a third party that included higher compensation and fewer terms. Accordingly, the Company has discontinued its efforts with Price Choice. "Over the past few months, we have learned a great deal about the retail 'embedded' marketplace and we've gained encouraging insight into the Hispanic markets. We believe there is a clear, open opportunity to provide smaller grocery chains with a pharmacy operation that will help them become more competitive with larger chains that offer full services, including pharmacy services," said Dr. Jordan Balencic, Chairman of the Board of Directors. He continued, "The key executives of Price Choice remain close to the Company, including Mr. Leo Smith, who is a member of our non-executive Advisory Board. We expect them to continue to assist us as we press forward."
Recent MITI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 05:45:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 07:56:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 02:15:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 06:03:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:11:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 02:23:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 09:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 05:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:28:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:12:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 08:34:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:00:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/13/2023 08:53:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 07:32:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:04:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/04/2023 04:27:09 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/22/2023 06:17:59 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/01/2023 08:38:54 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/29/2023 09:16:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:49:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM